These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23861189)

  • 1. Intrauterine red cell transfusion for anti-Kell isoimmunization in a fetus with Glanzmann's thrombasthenia.
    Unterscheider J; Ryan H; Morrison JJ; Malone FD
    Prenat Diagn; 2013 Nov; 33(11):1107-9. PubMed ID: 23861189
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.
    Kriplani A; Malhotra Singh B; Mandal K
    Gynecol Obstet Invest; 2007; 63(3):176-80. PubMed ID: 17143009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion.
    Lakhwani S; Machado P; Pecos P; Coloma M; Rebollo S; Raya JM
    Transfus Apher Sci; 2011 Aug; 45(1):9-11. PubMed ID: 21723196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero erythrocyte transfusion for fetal xerocytosis associated with severe anemia and non-immune hydrops fetalis.
    Ogburn PL; Ramin KD; Danilenko-Dixon D; Fairbanks VF; Ramsey PS
    Am J Obstet Gynecol; 2001 Jul; 185(1):238-9. PubMed ID: 11483935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy in mother with Glanzmann's thrombasthenia and isoantibody against GPIIb-IIIa: Is there a foetal risk?
    Léticée N; Kaplan C; Lémery D
    Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):139-42. PubMed ID: 16054952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis and perinatal outcome after intravascular transfusion].
    Monico-Ramos R; Ochoa-Flores M; Hernández-Herrera RJ; Flores-Pompa E
    Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization.
    Wikman A; Edner A; Gryfelt G; Jonsson B; Henter JI
    Transfusion; 2007 May; 47(5):911-7. PubMed ID: 17465958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four cordocenteses in one woman.
    Ulm B; Ulm MR; Deutinger J; Bernaschek G
    Fetal Diagn Ther; 1999; 14(5):283-5. PubMed ID: 10529571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model.
    Stowell SR; Arthur CM; Girard-Pierce KR; Sullivan HC; Santhanakrishnan M; Natarajan P; Patel SR; Tormey CA; Zimring JC; Hendrickson JE
    Haematologica; 2015 Oct; 100(10):e394-7. PubMed ID: 26185172
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrauterine transfusion with red cells and platelets.
    Moise KJ
    West J Med; 1993 Sep; 159(3):318-24. PubMed ID: 8236973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glanzmann's thrombasthenia and pregnancy. Contribution of plasma exchange before scheduled cesarean section].
    Vivier M; Treisser A; Naett M; Diemunsch P; Schmitt JP; Waller C; Tongio MM; Hemmendinger S; Lutz P
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(4):507-13. PubMed ID: 2778287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet transfusion in a patient affected by Glanzmann's thrombasthenia with antibodies against GPIIb-IIIa.
    Conte R; Cirillo D; Ricci F; Tassi C; Tazzari PL
    Haematologica; 1997; 82(1):73-4. PubMed ID: 9107089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD; Gordon MC; Higby K
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glanzmann's thrombasthenia and pregnancy.
    Walters JP; Hall JS
    West Indian Med J; 1990 Dec; 39(4):256-8. PubMed ID: 2082573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell transfusion in patients with type 1 Glanzmann's thrombasthenia.
    Laurian Y; Tisseron-Maury B; Bibi Triki T; Kaplan C; Gaudelus J
    J Thromb Haemost; 2005 Oct; 3(10):2346-7. PubMed ID: 16194208
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization.
    Bellucci S; Damaj G; Boval B; Rocha V; Devergie A; Yacoub-Agha I; Garderet L; Ribaud P; Traineau R; Socié G; Gluckman E
    Bone Marrow Transplant; 2000 Feb; 25(3):327-30. PubMed ID: 10673707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome.
    Zwiers C; van Kamp I; Oepkes D; Lopriore E
    Expert Rev Hematol; 2017 Apr; 10(4):337-344. PubMed ID: 28277805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraperitoneal transfusion in severe fetal hemolytic disease. Experience at the National Institute of Perinatology].
    Sentíes L; Garzon MT; Cabral F; Rosenfeld F; Karchmer S
    Ginecol Obstet Mex; 1986 Jan; 54():22-4, 26. PubMed ID: 3699489
    [No Abstract]   [Full Text] [Related]  

  • 20. Fetal cardiocentesis in care of severe Kell immunisation.
    Bakos O; Ewald U; Lindgren PG
    Fetal Diagn Ther; 1998; 13(6):372-4. PubMed ID: 9933822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.